Register now for Fin24 Dashboard and get access to portfolios, watchlists, financial comparison tools, and a whole lot more to help you achieve your financial goals.

Data provided by McGregor BFA
All data is delayed
Loading...
Where am I? Home
 
Prices are delayed by 15min.
Join the Fin24.com conversation about JSE-listed stock by using every time you tweet.

Discovery staunches price bleed

Feb 19 2009 18:23 Ines Schumacher

Related Articles

Financial services smorgasbord

Growth stocks 'set to blossom'

Medical schemes ripe for buyouts

'Medical costs won't spiral'

 

Top Stories

Cell C move sparks price war

May 27 2012 11:21

There's a price war raging between South Africa's cellphone networks after Cell C lowered the rates of its prepaid calls by more than 34%.

MyCiti buses running at a loss

May 28 2012 07:53

The City of Cape Town has spent R175m running the Myciti bus service since the Soccer World Cup compared to an income of R35m, a report says.

Another golf estate victim

May 27 2012 13:09

The oversupply of golf estates has claimed another victim.

 
Share Share line Print

Johannesburg - Medical insurance business Discovery Holdings staunched a nine-day share price decline on Thursday after issuing improved financial numbers - but uncertainty continues about the health of its offshore ventures.

Discovery gained as much as 6% intra-day and closed 4.5% higher on the JSE at 2 445c/share. This was after retreating from more than 2 600c/share on February 10 down to 2 380c/share, a value loss analysts said was related to apprehension ahead of its half-year figures ended December.

It was possible that investors were spooked after not receiving an alert from Discovery to inform them that earnings would be a fifth higher, an analyst said.

In terms of JSE reporting standards, public companies are required to inform shareholders of a 20% or more change in expected earnings levels.

Discovery Holdings reported a 19% increase in interim headline share earnings to R489m. Operating profit was about a fifth higher to R746m, after including its loss-making UK business units. Discovery Holdings declared an interim dividend of 25.5c/share.

In general terms, the company's healthcare business performed well but the global recession put pressure on Discovery's UK businesses and would continue to do so, analysts said.

"Investors have not fully bought into the offshore story," said Paul Theron, an analyst at Vestact. "Discovery has a good business but there's some anxiety about whether the UK business will prosper," he said.

PruProtect, Discovery's joint venture with the UK's Prudential Plc, posted a R104m loss in the six months to December. Discovery Holdings said this loss was in line with expectations, but Theron raised a flag over the business unit.

"Discovery faces more challenges in the UK. It will be targeting break-even but it's possible it'll come up short again," he said.

However, the flagship healthcare business, Discovery Health, would continue to perform well, said Wilhelm Hertzog, an analyst for Cape-based asset management firm Re:CM.

"Discovery has a unique product offering," said Hertzog. "This means it can afford to raise premiums because it has quite a sticky client base," he said. This was also true for Discovery's Life business, where profit margins were under pressure as it wrote more (lower margin) investments only business.

Discovery Holdings' income statement shows that claims increased 23% to R1.2bn. However, insurance premium revenue has increased by nearly 30% to R2.5bn from R2bn in the comparable period.

Most of this growth is driven by Discovery Life - it grew from R1 424m to R1 951m, an increase of R527m. This growth in premium revenue was driven by strong business growth and by inflation related increases," said Ricky Farber, CFO of Discovery Holdings.

"Over the past few days, Discovery shares were being sold because it didn't release a trading statement," said Hertzog. "That scared investors a bit."

The upward movement of the share price meant the market was now taking comfort in Discovery's good results, he said.

- Fin24.com

 
 
Comment on this story
0 comments
Comments have been closed for this article.
It pays to know the cost and what you’re getting in return
May 28 2012 09:33

Investors may not have a clue what they’re paying their money managers or they type of service they’re getting, or, whether they can actually negotiate lower fees. (Reuters)

Sasha

"In the short term this is true, Greece will dominate the headlines on a day to day basis, until their next elections when there would be some clarity to answer the question, "What next for Greece?" Amazingly everyone except the politicians seem to be lining themselves up for worst case scenario, b... Read their blog...

Recently updated
Podcasts
The Sishen saga

Legal expert Peter Leon on the increasingly complex legal wrangle over the Sishen Iron Ore mine. Time: 8:17 Listen Here...

Before you list

Is the clarion call of the JSE calling? Listen to Fin24’s expert panel discussion before you list your small business. Time: 17:29

Compare and Buy

Compare and apply for hundreds of financial products from many suppliers.

Credit cards Medical aid Current accounts Think Money

Money Clinic

Money Clinic Do you have a question about your finances? We'll get an expert opinion.
Click here...

Loading...